Special Populations and Immune Checkpoint Inhibitors: Are They Safe?
Keeping Current CME
English - February 26, 2021 15:22 - 31 minutes - 21.6 MB - ★★★★ - 22 ratingsScience Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In this activity, three experts discuss how to incorporate immune checkpoint inhibitor therapy into the management of individuals classified as part of the “special population” of patients not generally included in clinical trials.
Earn Credit / Learning Objectives & Disclosures:
https://www.medscape.org/viewarticle/946383?src=mkm_podcast_addon_946383